Piramal Pharma Limited (PPLPHARMA) Share Analysis
NSE · Healthcare · Pharmaceuticals
Piramal Pharma Limited (NSE: PPLPHARMA) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY Healthcare Index, NIFTY MidSmallcap 400. As of 14 Nov 2026, the share price was ₹245.00, ROE -3.83%.
Get the AI verdict on PPLPHARMA: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
PPLPHARMA chart with trendlines
Is PPLPHARMA a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Piramal Pharma Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
PPLPHARMA key facts
| Price and valuation | |
|---|---|
| Share price | ₹245.00 |
| Market cap | ₹32,557 Cr |
| P/B ratio | 4 |
| EPS | ₹-1.57 |
| Book value per share | ₹61.20 |
| Dividend yield | 0% |
| 52-week range | |
| 52-week high | ₹250.40 |
| 52-week low | ₹132.30 |
| Face value | ₹10.00 |
| Shareholding pattern | |
| Promoters | 34.8% |
| FIIs | 13.65% |
| DIIs | 14.43% |
| Public | 36.72% |
Index membership: NIFTY 500, NIFTY Healthcare Index, NIFTY MidSmallcap 400, NIFTY Pharma, NIFTY Smallcap 100, NIFTY Smallcap 250, NIFTY Smallcap 50.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.